STOCK TITAN

AptarGroup (ATR) Segment President sells 3,500 shares in open market

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

APTARGROUP, INC. Segment President Gael Touya reported an open-market sale of company stock. On February 18, 2026, he sold 3,500 shares of common stock at a weighted average price of $141.3539 per share, executed in multiple trades between $141.2250 and $141.8050. After this transaction, he directly owned 27,963 shares of AptarGroup common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Touya Gael

(Last) (First) (Middle)
APTARGROUP, INC.
265 EXCHANGE DRIVE, SUITE 301

(Street)
CRYSTAL LAKE IL 60014

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
APTARGROUP, INC. [ ATR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Segment President
3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/18/2026 S 3,500 D $141.3539(1) 27,963 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.2250 to $141.8050 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth.
Gael Touya by Irene Hudson as attorney-in-fact 02/19/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AptarGroup (ATR) report for Gael Touya?

AptarGroup reported that Segment President Gael Touya sold 3,500 shares of common stock. The sale was an open-market transaction and left him holding 27,963 shares directly following the trade.

At what price did Gael Touya sell AptarGroup (ATR) shares?

Gael Touya sold his AptarGroup shares at a weighted average price of $141.3539 per share. The shares were sold in multiple trades with prices ranging from $141.2250 to $141.8050, according to the filing footnote.

How many AptarGroup (ATR) shares does Gael Touya own after the Form 4 sale?

After the reported sale, Gael Touya directly owns 27,963 AptarGroup common shares. The Form 4 shows this figure as the total number of shares held following his 3,500-share open-market disposition on February 18, 2026.

What does the Form 4 say about the pricing of Gael Touya’s AptarGroup (ATR) share sale?

The Form 4 notes that the reported price is a weighted average. Shares were sold in multiple transactions with prices between $141.2250 and $141.8050, and detailed trade-level pricing is available upon request as stated in the footnote.

Was Gael Touya’s AptarGroup (ATR) transaction a buy or a sell?

The transaction reported for Gael Touya was a sale of AptarGroup common stock. The filing classifies it as an open-market sale under transaction code “S,” with 3,500 shares disposed of on February 18, 2026.
Aptargroup

NYSE:ATR

ATR Rankings

ATR Latest News

ATR Latest SEC Filings

ATR Stock Data

9.22B
63.64M
Medical Instruments & Supplies
Plastics Products, Nec
Link
United States
CRYSTAL LAKE